The expression of melanopsin and clock genes in Xenopus laevis melanophores and their modulation by melatonin

Vertebrates have a central clock and also several peripheral clocks. Light responses might result from the integration of light signals by these clocks. The dermal melanophores of Xenopus laevis have a photoreceptor molecule denominated melanopsin (OPN4x). The mechanisms of the circadian clock involve positive and negative feedback. We hypothesize that these dermal melanophores also present peripheral clock characteristics. Using quantitative PCR, we analyzed the pattern of temporal expression of Opn4x and the clock genes Per1, Per2, Bmal1, and Clock in these cells, subjected to a 14-h light:10-h dark (14L:10D) regime or constant darkness (DD). Also, in view of the physiological role of melatonin in the dermal melanophores of X. laevis, we determined whether melatonin modulates the expression of these clock genes. These genes show a time-dependent expression pattern when these cells are exposed to 14L:10D, which differs from the pattern observed under DD. Cells kept in DD for 5 days exhibited overall increased mRNA expression for Opn4x and Clock, and a lower expression for Per1, Per2, and Bmal1. When the cells were kept in DD for 5 days and treated with melatonin for 1 h, 24 h before extraction, the mRNA levels tended to decrease for Opn4x and Clock, did not change for Bmal1, and increased for Per1 and Per2 at different Zeitgeber times (ZT). Although these data are limited to one-day data collection, and therefore preliminary, we suggest that the dermal melanophores of X. laevis might have some characteristics of a peripheral clock, and that melatonin modulates, to a certain extent, melanopsin and clock gene expression.

Modulation of host cell signaling pathways as a therapeutic approach in periodontal disease

Recently, new treatment approaches have been developed to target the host component of periodontal disease. This review aims at providing updated information on host-modulating therapies, focusing on treatment strategies for inhibiting signal transduction pathways involved in inflammation. Pharmacological inhibitors of MAPK, NFκB and JAK/STAT pathways are being developed to manage rheumatoid arthritis, periodontal disease and other inflammatory diseases. Through these agents, inflammatory mediators can be inhibited at cell signaling level, interfering on transcription factors activation and inflammatory gene expression. Although these drugs offer great potential to modulate host response, their main limitations are lack of specificity and developments of side effects. After overcoming these limitations, adjunctive host modulating drugs will provide new therapeutic strategies for periodontal treatment.

Modulation of plasma levels and percentages of incorporation of ω-3 PUFAs in egg yolk under the influence of supplementation sources rich in omega 3 to diet of laying

Hundred forty-four Shaver White laying hens were used over a 4 week experimental period to investigate the effect of 3% of soybean oil, corn oil (MIL), canola oil, flaxseed oil (LIN), salmon oil (SAL) or tuna and sardine oil (SR/AT) added to the diets, upon the fatty acid egg yolk composition, blood plasma levels and incorporation time of each fatty acid into the egg yolk. Hens were allocated into 72 cages and the experimental design was a 6 x 6 randomized factorial model. Hens fed 3% of different oils, responded with increased polyunsaturated fatty acids omega 3 (ω-3 PUFAs), except for corn oil. The addition of flaxseed, soybean or corn oil into the diet increased the PUFAs levels into the egg yolk and in the blood plasma. Adding tuna and sardine oil into the diet increased the concentration of yolk saturated fatty acids. The levels of ω-3 PUFAs were increased in the tuna and sardine oil treatment, while the flaxseed oil increased the plasma fatty acids. The deposition of 349.28 mg/yolk of a-linolenic fatty acids (ALA) was higher in the group fed LIN, while the higher equal to 157.13 mg DHA/yolk was observed in group SR/AT. In the plasma, deposition increased from 0.33% (MIL) for 6.29% ALA (LIN), while that of DHA increase of 0.47% (MIL) for 4.24% (SAL) and 4.48% (SR/AT) and of 0.98% (MIL) for 6.14% (SR/AT) and 8.44% (LIN) of ω-3 PUFAs. The percentage of EPA into the yolk and plasma was higher for the hens fed 3% tuna and sardine oil diet, as well as the levels of yolk DHA. The concentration of DHA into the plasma was higher for the salmon and tuna/sardine oil treatments. The PUFAs yolk decreased during the first eight days of experiment, while the ω-3 PUFAs increased during the same period. The concentration of ALA increased until ten days of experiment, while the percentage of EPA and DHA increased up to the eighth experimental day

MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation

Hyperthyroidism promotes cardiac hypertrophy and the Angiotensin type 1 receptor (AT1R) has been demonstrated to mediate part of this response. Recent studies have uncovered a potentially important role for the microRNAs (miRNAs) in the control of diverse aspects of cardiac function. Then, the objective of the present study was to investigate the action promoted by hyperthyroidism on β-MHC/miR-208b expression and on α-MHC/miR-208a expression, as well as the possible contribution of the AT1R in this event. The findings of this study confirmed that AT1R is a key mediator of the cardiac hypertrophy induced by hyperthyroidism. Additionally, we demonstrated that like β-MHC, miR-208b was down-regulated in the hyperthyroid group. Similarly, like the expression of its host gene, α-MHC, miR-208a expression was up-regulated in response to hyperthyroidism. Finally, our data suggest for the first time that AT1R mediates the hyperthyroidism-induced increase on cardiac miRNA-208a/α-MHC levels, while does not influence on the reduction of miRNA-208b/β-MHC levels.

Liver accumulation of Plasmodium chabaudi-infected red blood cells and modulation of regulatory T Cell and dendritic cell responses

It is postulated that accumulation of malaria-infected Red Blood Cells (iRBCs) in the liver could be a parasitic escape mechanism against full destruction by the host immune system. Therefore, we evaluated the in vivo mechanism of this accumulation and its potential immunological consequences. A massive liver accumulation of P. c. chabaudi AS-iRBCs (PciRBCs) was observed by intravital microscopy along with an over expression of ICAM-1 on day 7 of the infection, as measured by qRT-PCR. Phenotypic changes were also observed in regulatory T cells (Tregs) and dendritic cells (DCs) that were isolated from infected livers, which indicate a functional role for Tregs in the regulation of the liver inflammatory immune response. In fact, the suppressive function of liver-Tregs was in vitro tested, which demonstrated the capacity of these cells to suppress naive T cell activation to the same extent as that observed for spleen-Tregs. On the other hand, it is already known that CD4+ T cells isolated from spleens of protozoan parasite-infected mice are refractory to proliferate in vivo. In our experiments, we observed a similar lack of in vitro proliferative capacity in liver CD4+ T cells that were isolated on day 7 of infection. It is also known that nitric oxide and IL-10 are partially involved in acute phase immunosuppression; we found high expression levels of IL-10 and iNOS mRNA in day 7-infected livers, which indicates a possible role for these molecules in the observed immune suppression. Taken together, these results indicate that malaria parasite accumulation within the liver could be an escape mechanism to avoid sterile immunity sponsored by a tolerogenic environment.

P2Y1 receptors expressed by C1 neurons determine peripheral chemoreceptor modulation of breathing, sympathetic activity, and blood pressure

Catecholaminergic C1 cells of the rostral ventrolateral medulla (RVLM) are key determinants of the sympathoexcitatory response to peripheral chemoreceptor activation. Overactivation of this reflex is thought to contribute to increased sympathetic activity and hypertension; however, molecular mechanisms linking peripheral chemoreceptor drive to hypertension remain poorly understood. We have recently determined that activation of P2Y1 receptors in the RVLM mimicked effects of peripheral chemoreceptor activation. Therefore, we hypothesize that P2Y1 receptors regulate peripheral chemoreceptor drive in this region. Here, we determine whether P2Y1 receptors are expressed by C1 neurons in the RVLM and contribute to peripheral chemoreceptor control of breathing, sympathetic activity, and blood pressure. We found that injection of a specific P2Y1 receptor agonist (MRS2365) into the RVLM of anesthetized adult rats increased phrenic nerve activity (≈55%), sympathetic nerve activity (38±6%), and blood pressure (23±1 mm Hg), whereas application of a specific P2Y1 receptor antagonist (MRS2179) decreased peripheral chemoreceptor–mediated activation of phrenic nerve activity, sympathetic nerve activity, and blood pressure. To establish that P2Y1 receptors are expressed by C1 cells, we determine in the brain slice preparation using cell-attached recording techniques that cells responsive to MRS2365 are immunoreactive for tyrosine hydroxylase (a marker of C1 cells), and we determine in vivo that C1-lesioned animals do not respond to RVLM injection of MRS2365. These data identify P2Y1 receptors as key determinants of peripheral chemoreceptor regulation of breathing, sympathetic nerve activity, and blood pressure.

Modulation of epidermial growth factor receptor signaling in colon adenocarcinoma

The use of agents targeting EGFR represents a new frontier in colon cancer therapy. Among these, monoclonal antibodies (mAbs) and EGFR tyrosine kinase inhibitors (TKIs) seemed to be the most promising. However they have demonstrated low utility in therapy, the former being effective at toxic doses, the latter resulting inefficient in colon cancer. This thesis work presents studies on a new EGFR inhibitor, FR18, a molecule containing the same naphtoquinone core as shikonin, an agent with great anti-tumor potential. In HT-29, a human colon carcinoma cell line, flow cytometry, immunoprecipitation, and Western blot analysis, confocal spectral microscopy have demonstrated that FR18 is active at concentrations as low as 10 nM, inhibits EGF binding to EGFR while leaving unperturbed the receptor kinase activity. At concentration ranging from 30 nM to 5 μM, it activates apoptosis. FR18 seems therefore to have possible therapeutic applications in colon cancer. In addition, surface plasmon resonance (SPR) investigation of the direct EGF/EGFR complex interaction using different experimental approaches is presented. A commercially available purified EGFR was immobilised by amine coupling chemistry on SPR sensor chip and its interaction to EGF resulted to have a KD = 368 ± 0.65 nM. SPR technology allows the study of biomolecular interactions in real-time and label-free with a high degree of sensitivity and specificity and thus represents an important tool for drug discovery studies. On the other hand EGF/EGFR complex interaction represents a challenging but important system that can lead to significant general knowledge about receptor-ligand interactions, and the design of new drugs intended to interfere with EGFR binding activity.

Caratterizzazione e generazione di segnali PWM per amplificatori in classe D ad alta efficienza

The convergence of information technology and consumer electronics towards battery powered portable devices has increased the interest in high efficiency, low dissipation amplifiers. Class D amplifiers are the state of the art in low power consumption and high performance amplification. In this thesis we explore the possibility of exploiting nonlinearities introduced by the PWM modulation, by designing an optimized modulation law which scales its carrier frequency adaptively with the input signal's average power while preserving the SNR, thus reducing power consumption. This is achieved by means of a novel analytical model of the PWM output spectrum, which shows how interfering harmonics and their bandwidth affect the spectrum. This allows for frequency scaling with negligible aliasing between the baseband spectrum and its harmonics. We performed low noise power spectrum measurements on PWM modulations generated by comparing variable bandwidth, random test signals with a variable frequency triangular wave carrier. The experimental results show that power-optimized frequency scaling is both feasible and effective. The new analytical model also suggests a new PWM architecture that can be applied to digitally encoded input signals which are predistorted and compared with a cosine carrier, which is accurately synthesized by a digital oscillator. This approach has been simulated in a realistic noisy model and tested in our measurement setup. A zero crossing search on the obtained PWM modulation law proves that this approach yields an equivalent signal quality with respect to traditional PWM schemes, while entailing the use of signals whose bandwidth is remarkably smaller due to the use of a cosine instead of a triangular carrier.

Modulation der Immunogenität von humanen Nierenzellkarzinomzellen durch stabilen TAP1-Gentransfer

Bei Nierenzellkarzinomen (NZK), wie auch bei vielen anderen Tumoren konnte eine reduzierte Expression der Klasse I Haupthistokompatibilitäts-Komplexe (MHC Klasse I) nachgewiesen werden, die assoziiert sein kann mit der gestörten Expression oder Funktion von Komponenten der Antigenprozessierung. Eine verminderte Erkennung solcher Tumore durch zytotoxische T-Lymphozyten und ein Zusammenhang mit einem Fortschreiten der Erkrankung führte zu der Annahme, daß es sich bei diesen Störungen um "immune escape"-Mechanismen handelt. Um die Bedeutung des heterodimeren Peptidtransporters TAP ("transporter associated with antigen processing") für die Immunogenität von Nierenzellkarzinomen zu untersuchen, wurde im Rahmen dieser Arbeit erstmals der stabile Gentransfer des humanen TAP1A-Gens in Nierenzellkarzinom-Zellen erfolgreich durchgeführt.
Dies konnte durch die Optimierung der Transfektionsmethode und des verwendeten Plasmid-Vektors erreicht werden. Die Transfektionen wurden mit Hilfe der Rechteck-Impuls-Elektroporation unter spezifischen, in der Arbeit etablierten Bedingungen durchgeführt. Der CMV-regulierte TAP-Expressions-Vektor wurde dahingehend verbessert, daß durch die Einführung einer IRES ("internal ribosomal entry site") Sequenz eine bicistronische m-RNS transkribiert wird, die sowohl das TAP1-Transgen als auch den Neomycin-Selektionsmarker enthält.
Es konnte nach klonaler Selektion eine stabile, aber unter den sieben getesteten Klonen heterogene Transkription der transgenen TAP1-mRNS nachgewiesen werden. In der Protein-Expression zeigten 5/7 der TAP1A-positive Klone eine mindestens zweifache Induktion der TAP1-Expression. In 2/7 dieser TAP1A-positive Klone war die TAP1-Überexpression mit einer Erhöhung der MHC Klasse I-Expression und selektiver Induktion des HLA-A2-Moleküls in der Durchflußzytometrie verbunden. Eine Quantifizierung des Peptidtransportes ergab je nach verwendetem Modellpeptid eine geringe oder gar keine Erhöhung der Transportrate in den TAP1-Transfektanden gegenüber Kontrollzellen. Ebenfalls konnte in Zytotoxizitäts-Analysen mit einer autologen T-Zellinie eine Erhöhung der spezifischen Lyse nicht gezeigt werden. Jedoch wurden im Zellkultur-Überstand dieser Zytotoxizitäts-Analysen bei einigen TAP1A-positive Transfektanden gegenüber mock transfizierten-Kontrollzellen deutlich erhöhte Werte des Tumornekrose-Faktor-alpha (TNF-alpha) gemessen, was als Maß einer T-Zell-Aktivierung gilt. Diese Ergebnisse sind konsistent mit einer ebenfalls deutlich gesteigerten T-Zell-Proliferation in Anwesenheit von TAP1A-positive Transfektanden.
Die alleinige stabile Überexpression von TAP1 in Nierenzellkarzinomzellen kann somit zu einer Modulation der MHC Klasse I-Expression und der T-Zell-Reaktivität führen. Das weist darauf hin, daß eine starke, konstitutive TAP1-Expression eine grundlegende Voraussetzung für eine effiziente Antigenprozessierung und Immunantwort darstellt und die Immuntoleranz gegenüber NZK durch stabilen TAP1-Gentransfer beinflußbar ist. Eine denkbare klinische Anwendung dieser Technik ist die Herstellung einer Tumorantigen-präsentierenden Zellvakzine, die eine T-Zell-Anergie gegenüber NZK durchbrechen könnte.
Schlüsselwörter: TAP, MHC, Antigenprozessierung, Tumorimmunologie, Gentransfer

Molecular analysis of Sigma-1 receptor modulation of the dopamine transporter

Sigma (σ) receptors are well established as a non-opioid, non-phencyclidine, and haloperidol-sensitive receptor family with its own binding profile and a characteristic distribution in the central nervous system (CNS) as well as in endocrine, immune, and some peripheral tissues. Two σ receptors subtypes, termed σ1 and σ2, have been pharmacologically characterized, but, to date, only the σ1 has also been cloned. Activation of σ1 receptors alter several neurotransmitter systems and dopamine (DA) neurotrasmission has been often shown to constitute an important target of σ receptors in different experimental models; however the exact role of σ1 receptor in dopaminergic neurotransmission remains unclear. The DA transporter (DAT) modulates the spatial and temporal aspects of dopaminergic synaptic transmission and interprer the primary mechanism by wich dopaminergic neurons terminate the signal transmission. For this reason present studies have been focused in understanding whether, in cell models, the human subtype of σ1 (hσ1) receptor is able to directly modulate the human DA transporter (hDAT). In the first part of this thesis, HEK-293 and SH-SY5Y cells were permanently transfected with the hσ1 receptor. Subsequently, they were transfected with another plasmid for transiently expressing the hDAT. The hDAT activity was estimated using the described [3H]DA uptake assay and the effects of σ ligands were evaluated by measuring the uptaken [3H]DA after treating the cells with known σ agonists and antagonists. Results illustrated in this thesis demonstrate that activation of overexpressed hσ1 receptors by (+)-pentazocine, the σ1 agonist prototype, determines an increase of 40% of the extracellular [3H]DA uptake, in comparison to non-treated controls and the σ1 antagonists BD-1047 and NE-100 prevent the positive effect of (+)-pentazocine on DA reuptake DA is likely to be considered a neurotoxic molecule. In fact, when levels of intracellular DA abnormally invrease, vescicles can’t sequester the DA which is metabolized by MAO (A and B) and COMT with consequent overproduction of oxygen reactive species and toxic catabolites. Stress induced by these molecules leads cells to death. Thus, for the second part of this thesis, experiments have been performed in order to investigate functional alterations caused by the (+)-pentazocine-mediated increase of DA uptake; particularly it has been investigated if the increase of intracellular [DA] could affect cells viability. Results obtained from this study demonstrate that (+)-pentazocine alone increases DA cell toxicity in a concentration-dependent manner only in cells co-expressing hσ1 and hDAT and σ1 antagonists are able to revert the (+)-pentazocine-induced increase of cell susceptibility to DA toxicity. In the last part of this thesis, the functional cross-talking between hσ1 receptor and hDAT has been further investigated using confocal microscopy. From the acquired data it could be suggested that, following exposure to (+)-pentazocine, the hσ1 receptors massively translocate towards the plasma membrane and colocalize with the hDATs. However, any physical interaction between the two proteins remains to be proved. In conclusion, the presented study shows for the first time that, in cell models, hσ1 receptors directly modulate the hDAT activity. Facilitation of DA uptake induced by (+)-pentazocine is reflected on the increased cell susceptibility to DA toxicity; these effects are prevented by σ1 selective antagonists. Since numerous compounds, including several drugs of abuse, bind to σ1 receptors and activating them could facilitate the damage of dopaminergic neurons, the reported protective effect showed by σ1 antagonists would represent the pharmacological basis to test these compounds in experimental models of dopaminergic neurodegenerative diseases (i.e. Parkinson’s Disease).

Analyse und Modulation kontaktallergischer Reaktionen

Analyse und Modulation kontaktallergischer Reaktionen In der vorliegenden Arbeit wurde in einem ersten Teil die Bedeutung des Tumor-Necrosis-Faktors auf eine Kontaktallergie anhand von TNFR1- und TNFR2-defizienten Mäusen untersucht. Mit Hilfe des Ohrschwellungsverlaufs einer von DNFB ausgelösten kontaktallergischen Reaktion konnte bei TNFR1-defizienten Mäusen eine leichte Überreaktivität und bei TNFR2-defizienten Mäusen eine statistisch abgesicherte Überreaktivität festgestellt werden. Eine ebenfalls überreaktive Schwellungsreaktion konnte bei TNFR2-defizienten Mäusen, die vorher mit Oxazolon behandelt worden waren, beobachtet werden. In den anschließend durchgeführten histologischen Untersuchungen der Langerhans-Zellen aus den TNFR-defizienten Mäusen zeigten sich keine sichtbaren Differenzen in bezug auf MHC II-Expression und Verteilung der Zellen. Eine unterschiedliche Stimulationskapazität konnte bei Langerhans-Zellen, die aus TNFR1- bzw. TNFR2-defizienten Mäusen isoliert worden waren, nicht beobachtet werden.In Migrationsstudien, bei denen FITC als Kontaktallergen von Langerhans-Zellen aufgenommen, prozessiert und nach der Wanderung in die Lymphknoten präsentiert wurde, konnte keine verringerte Anzahl der migrierenden Zellen bei TNFR1-defizienten Mäusen festgestellt werden. Jedoch wurde eine reduzierte Anzahl FITC- und MHC II-doppelt-positiver Zellen aus TNFR2-defizienten Mäusen beobachtet.Um Aufschlüsse über die Expression von TNF-Rezeptoren auf murinen Langerhans-Zellen gewinnen zu können, wurde mit Hilfe von Epidermal Sheets, zytofluorometrischen Analysen und RT-PCR-Analysen von Langerhans-Zellen die Expression der TNF-Rezeptoren untersucht. In Vorversuchen konnte die Expression von TNF-Rezeptoren auf Fibroblasten und T-Zellen gefunden werden. Weiterhin konnten beide TNF-Rezeptoren auf der Keratinozyten-Zellinie PAM 212 nachgewiesen werden. Auf frisch isolierten Langerhans-Zellen, die mittels MicroBeads aus epidermalen Zellsuspensionen gewonnen wurden, konnten keine TNF-Rezeptoren beobachtet werden. Bei kultivierten Langerhans-Zellen konnte dagegen die Expression des TNFR2 festgestellt werden. Mit Hilfe von RT-PCR-Analysen konnte die mRNA des TNFR1 sowohl bei frisch isolierten als auch bei kultivierten Langerhans-Zellen nachgewiesen werden. Im zweiten Teil der Arbeit wurde die Wirkung des Immunmodulators Leflunomid (LF) auf eine Kontaktallergie untersucht. Es konnte eine signifikant geringere Schwellungsreaktion im Zuge einer DNFB-induzierten Kontaktallergie bei LF-behandelten Mäusen festgestellt werden. Bei Experimenten zur Untersuchung des Wirkungszeitraums der inhibitorischen Wirkung von LF bei einer kontaktallergischen Reaktion konnte ein langanhaltender Effekt beobachtet werden. Weiterhin konnte die inhibitorische Wirkung von LF auf eine von Oxazolon induzierte kontaktallergische Schwellungsreaktion und auf eine irritative Schwellungsreaktion beobachtet werden. Wie in einem weiteren Experiment festgestellt werden konnte, wirkte LF größenteils antigenspezifisch.Der Wirkungszeitpunkt von LF konnte in verschiedenen Experimenten, bei dem LF vor, während oder nach der Sensibilisierungsreaktion verabreicht worden war, festgestellt werden. Eine suppressive Wirkung von LF war nur dann zu beobachten, wenn LF während der Sensibilisierungsphase gegeben worden war. Weiterhin konnte in Transfer-Experimenten festgestellt werden, daß die Inhibition der kontaktallergischen Schwellungsreaktion auf naive Tiere übertragbar ist. Außerdem wurden Hinweise gefunden, daß CD8+-T-Zellen als Effektorzellen bei der Suppression eine Rolle spielen. Desweiteren konnten anhand von Untersuchungen von Epidermal Sheets von LF-behandelten Mäusen, die mit DNFB konfrontiert worden waren, keine morphologischen Unterschiede gefunden werden. Nach Erstellung von Migrationsanalysen für die zum Einsatz gekommenen Versuchsgruppen, d.h. sowohl für die LF-behandelten als auch für die Kontroll-Mäuse, konnte kein Einfluß von LF auf die Wanderungsfähigkeit von LC konstatiert werden. Anhand von FACS-Analysen konnte bei einer mit LF kultivierten T-Zellinie eine reduzierte Expression des IL-2-, und Transferrin-Rezeptors, sowie von CD44 beobachtet werden. Schließlich wurde bei Untersuchungen einer topischen Applikationsform von LF festgestellt, daß LF nur oral appliziert wirksam war.

New discotic liquid crystals based on large polycyclic aromatic hydrocarbons as materials for molecular electronics

A series of new columnar discotic liquid crystalline materials based on the superphenalene (C96) core has been synthesized by oxidative cyclodehydrogenation with iron(III) chloride of suitable three-dimensional oligophenylene precursors. These compounds were investigated by means of differential scanning calorimetry (DSC), polarized optical microscopy (POM) and wide angle X-ray scattering (WAXS), and showed highly ordered supramolecular arrays and mesophase behavior over a broad temperature range. Good solubility, through the introduction of long alkyl chains, and the fact that these new superphenalene derivatives were found to be liquid crystalline at room temperature enabled the formation of highly ordered films (using the zone-casting technique), a requirement for application in organic electronic devices. The one-dimensional, intracolumnar charge carrier mobilities of superphenalene derivatives were determined using the pulse-radiolysis time-resolved microwave conductivity technique (PR-TRMC). Electrical properties of different C96-C12 architectures on mica surfaces were examined by using Electrostatic Force Microscopy (EFM) and Kelvin Probe Force Microscopy (KPFM). Hexa-peri-hexabenzocoronene (C42) derivatives substituted at the periphery with six branched alkyl ether chains were also synthesized. It was found that the introduction of ether groups within the side chains enhances the affinity of the discotic molecules towards polar surfaces, resulting in homeotropic self-assembly (as shown by POM and 2D-WAXS) when the compounds are processed from the isotropic state between two surfaces. A new, insoluble, superphenalene building block bearing six reactive sites was prepared, and was further used for the preparation of dendronized superphenalenes with bulky dendritic substituents around the core. UV/Vis and fluorescence experiments suggest reduced π-π stacking of the superphenalene cores as a result of steric hindrance between the peripheral dendritic units. A new family of graphitic molecules with partial ”zig-zag” periphery has been established. The incorporation of ”zig-zag” edges was shown to have a strong influence on the electronic properties of the new molecules (as studied by solution and solid-state UV/Vis, and fluorescence spectroscopy), leading to a significant bathochromic shift with respect to the parent PAHs (C42 and C96). The reactivity of the additional double bonds was examined. The attachment of long alkyl chains to a ”zig-zag” superphenalene core afforded a new, processable, liquid crystalline material.